Probiotic isolate APS strain of Brevibacterium for cholesterol reduction; exclusive license from CSIR-NCL; Eureka award winner; pre-clinical trials complete
Council of Scientific & Industrial Research, Extra Mural Research Division (CSIR-EMR), India
Quick Information
Thrust Areas
Pharmaceutical Sciences
Focus Area
Probiotics, cholesterol management
Sanction Amount
₹ Not specified
Status
Commercialised
Output
Status
Commercialised
TRL: Technology Readiness Level
Not specified
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
National Chemical Laboratory (NCL)
Accessibility Controls